Darunavir analog precursors target mitochondrial metabolism in multiple myeloma and CLL.

BupM-NH2, and particularly BnpM-NH2, showed enhanced cytotoxicity against MM, CLL, and NDMM cells compared to PBMCs by inducing apoptosis through autophagy and mitochondrial respiration inhibition. While the cytotoxic effect in RRMM is less pronounced and nonsignificant, BupM-NH2 and BnpM-NH2 induces stress in respiratory chain and mitochondria, which may re-sensitize resistant tumor cells to treatments. Therefore these compounds may hold promise as novel therapeutic agents for MM and CLL treatment.

Authors

Institutions

Publication Details

Journal
Cancer Cell International
Published
2025-12-23
DOI
https://doi.org/10.1186/s12935-025-04142-w
Primary Topic
Protein Degradation and Inhibitors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Darunavir analog precursors target mitochondrial metabolism in multiple myeloma and CLL.

Maria Francesca Armentano, Teodora Statuto, Paolo Lupattelli, Maria Funicello et al.
Cancer Cell International
Protein Degradation and Inhibitors
article

Darunavir analog precursors target mitochondrial metabolism in multiple myeloma and CLL.

Maria Francesca Armentano, Teodora Statuto, Paolo Lupattelli, Maria Funicello, Marisabel Mecca, Lucia Chiummiento, Salvatore Cortellino, Luciana Valvano, Enrico La Spina, Marzia Sichetti, Alessandro Santarsiere, Simona Picerno, Martina Giuseffi, Antonio Giordano, Eugenia Giglio, Alessandra Romano
article en

Abstract

BupM-NH2, and particularly BnpM-NH2, showed enhanced cytotoxicity against MM, CLL, and NDMM cells compared to PBMCs by inducing apoptosis through autophagy and mitochondrial respiration inhibition. While the cytotoxic effect in RRMM is less pronounced and nonsignificant, BupM-NH2 and BnpM-NH2 induces stress in respiratory chain and mitochondria, which may re-sensitize resistant tumor cells to treatments. Therefore these compounds may hold promise as novel therapeutic agents for MM and CLL treatment.

Cancer Cell InternationalVol. 26(1)
University of Siena (IT), Yahoo (United Kingdom) (GB), University of Basilicata (IT), University of Catania (IT), Centro di Riferimento Oncologico della Basilicata (IT), Scuola Superiore Meridionale (IT), Temple University (US), Sapienza University of Rome (IT)
Good health and well-being
Openalex Percentile: Top 37%
Protein Degradation and Inhibitors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.